CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV
BRACCO IMAGING CANADA
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV 52% has been permanently discontinued (last updated December 20, 2018). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is CHOLOGRAFIN MEGLUMINE INJ. - LIQ IV not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
02228556
Strength
52%
Dosage Form
LIQUID
Route
INTRAVENOUS
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from BRACCO IMAGING CANADA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02228564
41% · DIN 02229013
61% · DIN 02229021
76% · DIN 02229048
61% · DIN 02242122
76% · DIN 02242121
5MCG · DIN 02228602
529MG · DIN 02248302
279.3MG · DIN 02229056
DIN 02228599
8MCL · DIN 02287684
485.1MG · DIN 02567334